Gregorc, V., Cavina, R., Novello, S., Grossi, F., Lazzari, C., Capelletto, E., . . . Santoro, A. (2018). NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer. Oncologist.
Style de citation ChicagoGregorc, Vanesa, et al. "NGR‐hTNF and Doxorubicin As Second‐Line Treatment of Patients With Small Cell Lung Cancer." Oncologist 2018.
Style de citation MLAGregorc, Vanesa, et al. "NGR‐hTNF and Doxorubicin As Second‐Line Treatment of Patients With Small Cell Lung Cancer." Oncologist 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.